Software Healthcare Sector

RenovoRx

Market Cap: US$59.6m

A clinical-stage biopharmaceutical company, engages in developing targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment.

Born

Market Cap: US$59.5m

Does not have significant operations.

Sangamo Therapeutics

Market Cap: US$59.0m

A clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States.

Austco Healthcare

Market Cap: AU$82.4m

Engages in the business of development, manufacture, service, supply, and distribution of healthcare communications equipment and software in Australia, New Zealand, Asia, Europe, and North America.

Medinotec

Market Cap: US$58.7m

Engages in the research and development, production, and sale of medical devices for the treatment of vascular and airway diseases in South Africa, the United States, and internationally.

Daxor

Market Cap: US$58.4m

Engages in medical instrumentation and biotechnology operations.

Envoy Medical

Market Cap: US$57.9m

A hearing health company, provides medical technologies across the hearing loss spectrum.

Adaptin Bio

Market Cap: US$57.9m

A biotechnology company, develops drug delivery technologies to deliver drugs and other compounds directly to target destinations within the body in the United States.

Stablecoin Development

Market Cap: US$57.7m

Engages in the accumulation and holding of digital assets for participation in blockchain-based networks.

rYojbaba

Market Cap: US$56.9m

Provides consulting and health services to various customers in Japan.

Nutriband

Market Cap: US$56.7m

Develops a portfolio of transdermal pharmaceutical products in the United States.

Arovella Therapeutics

Market Cap: AU$78.6m

A biotechnology company, engages in the development of therapies for the treatment of cancer in Australia and internationally.

SkyAI

Market Cap: US$55.9m

Engages in building an Agentic finance for the global south.

Positron

Market Cap: US$55.8m

A medical technology company, co-develops, manufactures, and sells positron emission tomography and PET-computed tomography imaging systems in the United States.

Immutep

Market Cap: AU$78.1m

A biotechnology company, engages in developing novel Lymphocyte Activation Gene-3 related immunotherapies for cancer and autoimmune diseases in Australia.

Veri Medtech Holdings

Market Cap: US$55.7m

Through its subsidiaries, provides health and wellness services and products through its healthcare technology platform.

Clene

Market Cap: US$55.5m

A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics.

Circle8 Group

Market Cap: US$55.4m

Provides talent management services.

One Health Group

Market Cap: UK£40.5m

Provides diagnosis and treatment for orthopaedics, spine, general surgery, gynaecology, and urology patients.

Coiled Therapeutics

Market Cap: UK£40.5m

A clinical-stage oncology company, develops and commercialises clinical-stage oncology therapeutics in the United Kingdom and internationally.

Amplia Therapeutics

Market Cap: AU$77.0m

A clinical-stage drug development company, engages in the development of focal adhesion kinase (FAK) inhibitors for cancer and fibrosis in Australia.

Sensus Healthcare

Market Cap: US$55.0m

Operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide.

Sareum Holdings

Market Cap: UK£40.2m

A clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases.

biote

Market Cap: US$54.6m

Operates in practice-building business within the hormone optimization space.

Precipio

Market Cap: US$54.5m

A healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States.

Prescient Therapeutics

Market Cap: AU$75.7m

A clinical stage oncology company, develops drugs for the treatment of haematological and solid cancers in Australia.

Arch Biopartners

Market Cap: US$54.1m

Engages in the development of novel drugs for acute kidney injury and organ damage in Canada.

SomnoMed

Market Cap: AU$75.6m

SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe.

Hemogenyx Pharmaceuticals

Market Cap: UK£39.4m

A clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of treatments for blood cancer in the United Kingdom and the United States.

Apollomics

Market Cap: US$53.4m

A clinical-stage biopharmaceutical company, engages in the discovery and development of oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer.

Planet 13 Holdings

Market Cap: CA$73.8m

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.

Odonate

Market Cap: US$53.3m

A pharmaceutical company, develops therapeutics for the treatment of cancer.

Alps Group

Market Cap: US$53.2m

A biotechnology company, provides research and development, medical services, and wellness solutions for advanced therapies.

TScan Therapeutics

Market Cap: US$52.8m

A clinical-stage biotechnology company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States.

Vext Science

Market Cap: CA$73.1m

Through its subsidiaries, engages in integrated cannabis operations in the United States.

Avecho Biotechnology

Market Cap: AU$73.4m

A biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, France, and India.